Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Bristol Myers (BMY), TSVT CAR T-Cell Therapy to Face FDA's ODAC
12:05pm, Tuesday, 06'th Feb 2024
Bristol Myers (BMY) and its partner TSVT announce that the FDA's ODAC will meet in March to review data supporting the label expansion for CAR T-cell therapy.
Analyst: Positive Catalysts Can't Save This Pharma Stock
09:00am, Tuesday, 06'th Feb 2024
Biopharmaceutical stock Bristol-Myers Squibb Co (NYSE:BMY) is in focus this morning, after a downgrade to "neutral" from "buy" at Redburn-Atlantic.
Bristol Myers Squibb Shares Cross 5% Yield Mark
03:26pm, Monday, 05'th Feb 2024
In trading on Monday, shares of Bristol Myers Squibb were yielding above the 5% mark based on its quarterly dividend (annualized to $2.4), with the stock changing hands as low as $47.68 on the day. Di
Undervalued Gems: 7 Stocks Set for a Major Rebound
08:41am, Monday, 05'th Feb 2024
Focusing on undervalued stocks can be a rewarding investment strategy, but value investing is not as simple as finding the stocks trading at the lowest valuations, buying them, and waiting for big ret
Bristol-Myers Squibb: Massive Discount Spells Opportunity
08:05am, Sunday, 04'th Feb 2024
Bristol-Myers Squibb has faced revenue stagnation and a decline in stock price, but recent Q4 results suggest a potential rebound in top-line growth. BMY's in-line and new product portfolio showed str
5 Relatively Secure And Cheap Dividend Stocks To Invest In - February 2024
09:00am, Saturday, 03'rd Feb 2024
This article is part of our monthly series where we highlight five large-cap, relatively safe, dividend-paying companies offering large discounts to their historical norms. We go over our filtering pr
Bristol-Myers (BMY) Q4 Earnings & Sales Beat, Stock Gains
01:41pm, Friday, 02'nd Feb 2024
Bristol-Myers' (BMY) fourth-quarter 2023 earnings and sales surpass estimates as Reblozyl and Revlimid outperform. Shares rise on the same.
Bristol Myers Squibb Tops Earnings Estimates, Boosted by New Drug Sales
12:50pm, Friday, 02'nd Feb 2024
Bristol Myers Squibb (BMY) shares edged 0.7% higher in intraday trading Friday after posting better-than-expected results and guidance as it benefited from the addition of new drugs to its lineup.
Nonfarm Payrolls Increased More Than Expected
11:46am, Friday, 02'nd Feb 2024
The big jobs numbers out this week came from this morning's U.S. Bureau of Labor Statistics' (BLS) Employment Situation report, which surprised to the upside in a major way: 353K new jobs created for
BLS Jobs Up Big: 353K, 3.7% Unemployment
11:26am, Friday, 02'nd Feb 2024
353K new jobs created for January are nearly double the 180K or so analysts were looking for.
Compared to Estimates, Bristol Myers (BMY) Q4 Earnings: A Look at Key Metrics
10:31am, Friday, 02'nd Feb 2024
While the top- and bottom-line numbers for Bristol Myers (BMY) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics c
Bristol Myers' New Drugs Drive Upbeat Outlook. The Stock Is On the Mend.
07:38am, Friday, 02'nd Feb 2024
Bristol Myers Squibb's fourth-quarter earnings and revenue beat Wall Street expectations.
Bristol Myers posts better-than-expected 4th-quarter results
07:04am, Friday, 02'nd Feb 2024
Drugmaker Bristol Myers Squibb on Friday posted better-than-expected results for the fourth quarter as sales of its new anemia drug Reblozyl and its already off patent blood cancer drug Revlimid outpe
Bristol Myers Squibb results top expectations as newer drugs help fuel growth
07:01am, Friday, 02'nd Feb 2024
Bristol Myers Squibb Co. BMY, -0.41% on Friday reported fourth-quarter results that beat analysts' expectations, helped by portfolio stalwarts like the blood thinner Eliquis as well as strong growth a
The best trades of the last 50 years show what investors should do now
06:24am, Friday, 02'nd Feb 2024
Early Friday futures trading shows stock indices on the front foot. Whether they hold that optimism into Wall Street's opening bell may depend on labor market data.
